PLASMALYTE 148 IN WATER 30 MG / 100 ML — DIN 00260576
MAGNESIUM CHLORIDE : 30 MG / 100 ML POTASSIUM CHLORIDE : 37 MG / 100 ML SODIUM CHLORIDE : 526 MG / 100 ML SODIUM GLUCONATE : 502 MG / 100 ML SODIUM ACETATE : 368 MG / 100 ML · BAXTER CORPORATION · SOLUTION · wholesale supply in Canada
Health Canada status: CANCELLED POST MARKET
What is PLASMALYTE 148 IN WATER?
PLASMALYTE 148 IN WATER 30 MG / 100 ML contains MAGNESIUM CHLORIDE : 30 MG / 100 ML POTASSIUM CHLORIDE : 37 MG / 100 ML SODIUM CHLORIDE : 526 MG / 100 ML SODIUM GLUCONATE : 502 MG / 100 ML SODIUM ACETATE : 368 MG / 100 ML. It is listed in the Health Canada Drug Product Database under DIN 00260576, held by BAXTER CORPORATION, supplied as SOLUTION for INTRAVENOUS administration. Health Canada currently lists it as cancelled post market, status dated 04-Dec-2017. This Drug Identification Number is no longer authorized for sale in Canada, so Nexara does not supply it. The record is kept here because buyers still meet the number on old formularies, purchase orders and tender documents; Nexara can help identify an authorized alternative.
What is PLASMALYTE 148 IN WATER used for?
PLASMA-LYTE 148 Injection/PLASMA-LYTE A Injection are indicated for volume replacement, as a source of water and electrolytes, and as an alkalinizing agent.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
How much does Electrolytes cost around the world?
Electrolytes is listed on 2 of the national price registers Nexara ingests. Each country publishes on a different basis, so those figures are not comparable with one another — or with a Canadian wholesale price.
What a market publishes matters more than the number it publishes. Iceland publishes a max wholesale; Saudi Arabia publishes a public. Comparing an ex-factory ceiling against a pharmacy public price tells you nothing about either, and comparing either against a Canadian landed cost tells you less.
| Market | Price basis published there | Brands | Packs listed | Range |
|---|---|---|---|---|
| Iceland | max wholesale | 2 | 2 | ISK███.██ |
| Saudi Arabia | public | 1 | 1 | SAR███.██ |
3 pack listings across 3 brand entries and 2 price bases, refreshed 02 Sep 2026. Ranges span every Electrolytes pack in that market, so a high figure is usually a larger pack rather than the same product.
This table is a regulatory record of where the molecule is listed. The DIN on this page is no longer authorized for sale in Canada, so Nexara does not quote it — see the alternatives above.
Is there a generic Electrolytes in Canada, and who makes it?
Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.
4 holders have a Canadian DIN containing Electrolytes, across 20 DINs, of which 10 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.
| Market authorization holder | DINs | Marketed | Brand names | Position |
|---|---|---|---|---|
| BAXTER CORPORATION | 10 | 6 | (20MMOL/L) POTASSIUM CHLORIDE IN 0.9% SODIUM CHLORIDE INJECTION USP, (40 MMOL/L) POTASSIUM CHLORIDE IN 0.9% SODIUM CHLORIDE INJECTION USP, (40 MMOLS/L) POTASSIUM CHLORIDE IN LACTATED RINGER'S INJECTION USP, LACTATED RINGER'S INJECTION, USP, MULTIPLE ELECTROLYTE ADDITIVE LIQ FORMULA 1, +5 more | Sourceable in Canada |
| B. BRAUN MEDICAL INC | 5 | 3 | HYPERLYTE CR MULTI-ELECTROLYTE CONCENTRATE, ISOLYTE S (MULTI-ELECTROLYTE INJECTION), ISOLYTE S PH 7.4 (MULTI-ELECTROLYTE INJECTION), LACTATED RINGER'S INJECTION USP, RINGER'S INJECTION USP | Sourceable in Canada |
| ICU MEDICAL CANADA INC | 4 | 1 | LACTATED RINGER'S INJECTION, NORMOSOL-R, POTASSIUM CHLORIDE 20 MEQ IN 0.9% SODIUM CHLORIDE, POTASSIUM CHLORIDE 40 MEQ IN 0.9% SODIUM CHLORIDE | Sourceable in Canada |
| HOSPIRA HEALTHCARE ULC | 1 | 0 | PLEGISOL | No marketed DIN |
Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 30 MG / 100 ML |
|---|---|
| Dosage form | SOLUTION |
| Route | INTRAVENOUS |
| Pack configuration (monograph) | 1000 mL |
| Storage | Store at 15ºC to 25ºC. |
Pack detail is kept as a regulatory record. This DIN is no longer authorized for sale in Canada, so Nexara does not quote this pack.
Substance and classification
| Active substance | Electrolytes |
|---|---|
| ATC code | B05BB01 |
| AHFS class | 40:12.00 |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 00260576 |
|---|---|
| DIN (unpadded, as printed on some documents) | 260576 |
| Brand name | PLASMALYTE 148 IN WATER |
| Generic / active ingredient | MAGNESIUM CHLORIDE : 30 MG / 100 ML POTASSIUM CHLORIDE : 37 MG / 100 ML SODIUM CHLORIDE : 526 MG / 100 ML SODIUM GLUCONATE : 502 MG / 100 ML SODIUM ACETATE : 368 MG / 100 ML |
| Market authorization holder | BAXTER CORPORATION |
| Health Canada schedule | Ethical |
| ATC code | B05BB01 |
| ATC anatomical main group | B — Blood and blood-forming organs |
| ATC therapeutic subgroup | B05BB |
| Current status | CANCELLED POST MARKET |
| Status date | 04-Dec-2017 |
| Original market date | 1968-12-31 00:00:00 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
1 · Same molecule, other Canadian presentations
10 of 20 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.
| Product | Strength | Form | Holder | Health Canada status | DIN |
|---|---|---|---|---|---|
| (20MMOL/L) POTASSIUM CHLORIDE IN 0.9% SODIUM CHLORIDE INJECTION USP | 150 MG / 100 ML | SOLUTION | BAXTER CORPORATION | MARKETED | 00786209 |
| (40 MMOL/L) POTASSIUM CHLORIDE IN 0.9% SODIUM CHLORIDE INJECTION USP | 300 MG / 100 ML | LIQUID | BAXTER CORPORATION | MARKETED | 00786217 |
| ISOLYTE S (MULTI-ELECTROLYTE INJECTION) | 530 MG / 100 ML | SOLUTION | B. BRAUN MEDICAL INC | MARKETED | 01931628 |
| ISOLYTE S PH 7.4 (MULTI-ELECTROLYTE INJECTION) | 820 MCG / 100 ML | SOLUTION | B. BRAUN MEDICAL INC | MARKETED | 01931679 |
| LACTATED RINGER'S INJECTION | 3.1 MG | SOLUTION | ICU MEDICAL CANADA INC | MARKETED | 00039470 |
| LACTATED RINGER'S INJECTION USP | 20 MG / 100 ML | SOLUTION | B. BRAUN MEDICAL INC | MARKETED | 01931636 |
| LACTATED RINGER'S INJECTION, USP | 310 MG / 100 ML | SOLUTION | BAXTER CORPORATION | MARKETED | 00061085 |
| PLASMA-LYTE A INJECTION | 30 MG / 100 ML | SOLUTION | BAXTER CORPORATION | MARKETED | 02339358 |
| POTASSIUM CHLORIDE IN LACTATED RINGER'S INJECTION | 20 MG / 100 ML | LIQUID | BAXTER CORPORATION | MARKETED | 02243421 |
| POTASSIUM CHLORIDE IN SODIUM CHLORIDE INJECTION USP | 450 MG / 100 ML | SOLUTION | BAXTER CORPORATION | MARKETED | 02269414 |
2 · Same class — other molecules in ATC B05BB
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Electrolytes With Carbohydrates | (20 MMOL/L) POTASSIUM CHLORIDE IN 3.3% DEXTROSE AND 0.3% SODIUM CHLORIDE INJECTION USP · (20 MMOL/L) POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.9% SODIUM CHLORIDE INJECTION USP · (20 MMOL/L) POTASSIUM CHLORIDE IN 5% DEXTROSE INJECTION USP · (20MMOL/L) POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.2% SODIUM CHLORIDE INJECTION USP · +66 more | 70 | 17 | Yes |
| Electrolytes | (20MMOL/L) POTASSIUM CHLORIDE IN 0.9% SODIUM CHLORIDE INJECTION USP · (40 MMOL/L) POTASSIUM CHLORIDE IN 0.9% SODIUM CHLORIDE INJECTION USP · (40 MMOLS/L) POTASSIUM CHLORIDE IN LACTATED RINGER'S INJECTION USP · HYPERLYTE CR MULTI-ELECTROLYTE CONCENTRATE · +16 more | 20 | 10 | Yes |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
3 · Adjacent classes in ATC B05B
| ATC subgroup | Molecules | DINs | Marketed |
|---|---|---|---|
| B05BA | Amino Acids · Carbohydrates · Combinations · Fat Emulsions | 150 | 38 |
| B05BC | Carbamide · Carbamide, Combinations · Mannitol | 11 | 5 |
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
What else is PLASMALYTE 148 IN WATER called?
The same molecule, Electrolytes, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| ADDAMEL AMP. | Latin | Saudi Arabia |
| Hypertonic | Latin | Iceland |
| Ringer lactat Hartmann | Latin | Iceland |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.